The Lancet7d
Advances in diagnosis, classification, and management of pain in Parkinson's disease
With over 10 million people affected worldwide, Parkinson's disease is the fastest-growing neurological disorder. More than ...
Medscape5d
Parkinson’s Prevalence Projected to Double Globally by 2050
Global prevalence of Parkinson’s disease is expected to double by 2050, with aging and population growth driving the surge, a ...
Rolling Out9d
Early signs of Parkinson’s as cases predicted to double
Global Parkinson's cases projected to double by 2050. Learn the 8 early warning signs, from smell loss to voice changes, for ...
Labroots9d
Revealing How a Parkinson's Mutation Leads to Disease
Parkinson's Disease has an early onset form, which affects patients before they reach age 50, and is due to genetic mutations ...
Knowridge Science Report6d
AI software can diagnose Parkinson’s with 96% accuracy
Diagnosing Parkinson’s disease can be challenging, especially in its early stages. Studies show that doctors get it right ...
IRLAB Therapeutics: IRLAB to Initiate a Study of IRL757 in Parkinsons's Disease with Full Financial Backing from its Development Partner MSRD
ANNOUNCEMENT FOR EUROPEAN MEDICAL & PHARMACEUTICAL TRADE MEDIA AND EUROPEAN FINANCIAL MEDIA ONLY. GOTHENBURG, SE / ACCESS Newswire / March 27, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA), a comp ...
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Interim Analysis Expected End of 2Q 2025 BETHESDA, MD / ACCESS Newswire / March 14, 2025 / Gain Therapeutics, Inc. (Nasdaq:GANX) ...